Latest Announcements

Ather Energy Limited has informed the Exchange about Presentation for the quarter ended June 30, 2026, with a copy of the Investor Presentation on the Company’s performance for the quarter.

Quess Corp Limited has informed the Exchange about the Transcript of Earnings Call – Q1 FY27. The company delivered a consolidated revenue of Rs. 4,182 crores, reflecting a 15% year-on-year growth. The EBITDA during this quarter came in at Rs. 85 crores, with a margin at 2.02%. PAT stood at Rs. 82 crores, growing at 61% year-on-year and 28% quarter-on-quarter.

Mastek Limited has entered into a strategic Platinum Partnership with Innovaccer to accelerate AI-Powered Healthcare Transformation. The partnership will help healthcare organizations transform siloed data into actionable intelligence, improving care outcomes, lowering the cost of care and unlocking new AI-driven use cases.

Mastek Ltd has partnered with Innovaccer to accelerate AI-powered healthcare transformation through the Gravity Platform, a unified autonomous operations platform for healthcare.

Trident Lifeline Ltd has released its earnings presentation for Q1 & FY27, announcing a milestone of Rs 100 crore plus on both a standalone and consolidated basis. The company has demonstrated exceptional growth momentum with sustained improvement in scale and profitability. It has diversified its portfolio spanning pharmaceuticals, nutraceuticals, herbals, injectables, personal care, and medical devices. The company has also made strategic investments in new businesses to diversify its growth platform.

Quess Corp Ltd reported Q1 FY27 results with a 15% year-on-year revenue growth, 21% year-on-year EBITDA growth, and 61% year-on-year PAT growth. The company maintained a zero-debt position and declared a final dividend of Rs. 3 per share.

UPL Limited has released its Q1FY27 investor presentation, highlighting strong revenue and EBITDA growth, margin expansion, and improved ESG score. The company has received SEBI approval for the Advanta IPO and a ratings upgrade from CARE Edge. UPL maintains its inclusion in the FTSE4Good index and has improved its ESG score.

Senores Pharmaceuticals Limited has informed the Exchange regarding Transcript of Earnings Conference Call held on Monday, July 27, 2026 for Q1FY27.

TANFAC Industries Ltd. has announced its Q1 FY27 earnings, with revenue growing 6% YoY to INR187 crores. The company has completed a INR250 crores Qualified Institutional Placement and plans to issue a preferential share issue of INR100 crores. The company is net debt-free and has appointed a new President - Technical and Operations.

UPL Ltd. has announced its Q1FY27 investor presentation, highlighting a 10% increase in revenue and a 15% increase in EBITDA. The company has also achieved its seventh consecutive quarter of revenue and EBITDA growth, with a strong performance despite macro headwinds. UPL has maintained its FTSE4Good index inclusion with an improved ESG score of 4.4 vs. 4.1 LY. The company has also received a ratings upgrade from CARE Edge to AA+ (Stable).

UPL Limited has announced its unaudited financial results for Q1 FY 2027, reporting a 15% YoY growth in revenue and EBITDA, with a 10% YoY increase in margin. The company has maintained its net debt and improved its gearing ratios despite macro headwinds. UPL has guided for full-year revenue growth of 7-11% and EBITDA growth of 10-14%.

UPL Ltd has announced its unaudited Q1 FY 2027 financial results, showing a 15% YoY growth in revenue and EBITDA, with a 180 bps expansion in contribution margin. The company has maintained its net debt and improved its gearing ratios despite macro headwinds. UPL has guided for full-year revenue growth of 7-11% and EBITDA growth of 10-14%.

Blue Jet Healthcare Limited has informed the Exchange about Presentation on Financial Results for the first quarter ended June 30, 2026. The company has seen a 25% increase in revenue from operations, 38% increase in EBITDA, and 22% increase in PAT compared to the previous quarter. However, revenue from operations decreased by 17% and EBITDA decreased by 19% compared to the same quarter last year.

Senores Pharmaceuticals Limited has announced its Q1FY27 earnings conference call transcript, highlighting a healthy performance despite an uncertain operating environment. The company's diversified business portfolio and operational excellence enabled it to deliver consistent business performance and reinforce its long-term growth trajectory.

Sakar Healthcare Limited has informed the Exchange about Transcript of Con-Call for Q1 FY27 Earnings Conference Call, where the company discussed its operational and financial performance, highlighting growth in oncology business, market access, and product development.

Pine Labs Ltd has released its Q1 FY2027 earnings call transcript, highlighting a 20% year-on-year growth, strong EBITDA performance, and investments in forward-looking technologies.

Golkunda Diamonds & Jewellery Ltd has announced the commencement of domestic manufacturing operations at its new 5,360 sq. ft. facility in Andheri East, Mumbai, with an installed capacity of approximately 125-150 kg of jewellery per annum, expected to increase the Company’s overall manufacturing capacity by 50–60%.

Golkunda Diamonds & Jewellery Ltd has commenced its new manufacturing facility in India, expanding its domestic operations and increasing its overall manufacturing capacity by 50-60%. The new facility will cater to the growing Indian jewellery market and diversify the company's revenue streams.

Dhanuka Agritech Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, and has also made several other significant announcements, including the launch of 5 new products, the acquisition of land for a new manufacturing plant, and the introduction of an Employee Stock Option Plan.

NOCIL Ltd has released its Q1FY27 Investor Presentation, highlighting a 20% revenue growth on a year-on-year basis, driven by strong demand and improved customer engagements. The company has also reported a 9% volume growth and a 22% revenue growth on a quarter-on-quarter basis. NOCIL has emphasized its focus on strengthening core pillars, including product portfolio expansion, operational excellence, customer-centric growth, and responsible business practices.